SAMURA, B. Influence of atorvastatin therapy on biological markers and cardiovascular risk in patients with chronic lymphocytic leukemia in remission. Zaporozhye Medical Journal, [S. l.], n. 1, 2019. DOI: 10.14739/2310-1210.2019.1.155793. Disponível em: http://zmj.zsmu.edu.ua/article/view/155793. Acesso em: 2 may. 2024.